Early Detection Leaders

About Our Pathogen Analysis Strategies

A Message from Our Chairman

Dyne Immune Institute for Translational Medicine and Research has developed advanced technologies for the implementation of rapid-screening assays for the definitive analysis of all types and species of pathogens, being of viral, bacterial, parasitic, or protozoal in origin. We deliver extremely accurate data and analysis to a global scientific and medical community charged with tackling some of the toughest immunology issues on the planet.

Our advanced technological format, once applied, prevents exposure and therefore the insidious scenario of communicable infections within the confines of health care facilities. We’ve developed a rapid, non-instrument-based field assay for the antemortem screening of zoonotic vectors of rabies with an immunoassay format that requires just 15 minutes to obtain results.

The Rabies Rapid Screening Assay is performed by merely swabbing the suspect vector's oral cavity to obtain saliva samples. Those samples are then applied to a lateral flow assay specifically for the determination of the presence of the rabies virus. Our assay eliminates sacrificing the animal to obtain brain tissue samples which is the "gold standard" method that is prescribed by the Centers for Disease Control™ (CDC) and The World Health Organization™ (WHO).

Dr. Michael A. Huchital, Chairman, Chief Scientific Officer
Dyne Immune Institute for Translational Medicine and Research

We support the Global Benevolent Campaign

Our mission is to reduce morbidity and mortality and reduce emerging and re-emerging infectious diseases.

We will work with faith-based organizations and other groups to improve quality of life through nutritional, environmental, and socio-economic interventions.

Core Mission
We are committed to improving human health and quality of life worldwide by preventing the spread of infectious disease. We can reduce sickness and death by detecting disease early by working together with public and private groups.

Rabies is a concern worldwide and is in areas inhabited by over 3 billion people. The disease is reported to kill over 70,000 people a year (mostly in China, India, and Africa); however, according to the World Health Organization (WHO) the figure in Africa can be as high as 2.4 million people annually. What is needed is proof that the larger figure is true. Once the WHO is appraised of the results, rabies could become a higher global priority and many people's lives will be saved.

Global Benevolent Campaign- Interventions

  • Pneumonia - world’s biggest killer of children, killing 1.5-2 million each year
  • Hepatitis - kills 1 million people per year
  • Rabies - 70, 000 die per year, a child every 10 minutes
  • Chlamydia - 6 million people go blind each year in Africa
  • Polio 1, 2, and 3 – reemerging disease
  • Malaria - 3.3 billion people at risk
  • Cryptosporidium - can be serious, long-lasting, and sometimes fatal

Contact Dyne Immune in the Hudson Valley of New York, for rapid-screening assays
serving the needs of pathogen analysis in critical applications all over the world.